Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis: A Prospective Observational Study

NCT02922374 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT02922374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02922374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis: A Prospective Observational Study
Lead sponsor
Jinling Hospital, China
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2013
Completion date
December 31, 2016
Enrollment
117 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute severe colitis (asc)